Gut Healing is a recurring topic in our peptide coverage. This hub collects every article tagged Gut Healing, newest first, each evidence-graded and tied to real, verifiable sources.
An evidence-first ranking of the peptides studied for IBS — the FDA-approved GC-C agonists linaclotide and plecanatide, plus larazotide, BPC-157 and KPV — separating real human trials from preclinical promise and marketing hype.
A clinical monograph on Pentadeca Arginate (PDA) — the L-arginine salt of BPC-157 marketed for tendon, gut and wound healing. Zero PDA-specific studies, borrowed preclinical data, and an unsettled 2026 legal status.
A clinical monograph on Pentadeca Arginate — the L-arginine salt of BPC-157. No studies exist under the 'PDA' name; the borrowed parent evidence is 35:1 preclinical, with zero human RCTs and an unsettled 2026 legal status.
A clinical monograph on larazotide acetate (AT-1001) — the gut tight-junction regulator developed for celiac disease. Real Phase 2 symptom data, a failed Phase 3, and an unapproved 2026 legal status.
A clinical monograph on KPV — the anti-inflammatory tripeptide fragment of alpha-MSH. Deep rodent and cell-culture data for gut and skin inflammation, zero human trials, and an unsettled 2026 legal status.
A clinical monograph on teduglutide — the GLP-2 receptor agonist FDA-approved for short bowel syndrome with intestinal failure. Grade A RCT evidence for SBS-IF, a mandated neoplasia-surveillance burden, and unproven 'leaky-gut' hype.
A clinical monograph on alanyl-glutamine (Dipeptiven) — the stable dipeptide built to deliver glutamine intravenously. Grade-A but contested evidence in parenteral nutrition, with a major high-dose mortality signal.
A clinical monograph on BPC-157 — the stable gastric pentadecapeptide marketed for tendon, gut and wound healing. Deep preclinical data, no completed human RCT, and an unsettled 2026 legal status.
Gut Healing is a topic our editors cover across the site. This hub aggregates the related, evidence-graded guidance.
This hub updates automatically whenever a new article is tagged Gut Healing, so the latest coverage appears first.
Yes. Every article here grades its efficacy claims A-D and cites real, verifiable studies, regulatory documents or trial registries.
The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.
Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.
Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.
Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.
This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.